Wan D C, Powis D A, Marley P D, Livett B G
Department of Biochemistry, University of Melbourne, Parkville, Victoria, Australia.
Biochem Pharmacol. 1988 Feb 15;37(4):725-36. doi: 10.1016/0006-2952(88)90147-5.
The effects of a number of alpha- and beta-adrenoceptor agonists and antagonists on the modulation of secretion from bovine adrenal chromaffin cells were investigated. Secretion was induced by nicotine, 56 mM K+, histamine or Ba2+ and was detected by the ATP luciferin-luciferase bioluminescence technique or by the measurement of endogenous catecholamines (CA) by HPLC coupled with electrochemical detection. ATP release from freshly isolated cells by 5 microM nicotine was only weakly inhibited by adrenaline and noradrenaline and even then required high concentrations (greater than 500 microM), while dopamine (1 microM-1 mM) and isoproterenol (100 microM) had no effect. Clonidine (100 microM), oxymetazoline (100 microM), yohimbine (100 microM), and propranolol (5 microM) all produced inhibition of nicotine-induced ATP release with the order of potency:propranolol greater than oxymetazoline greater than clonidine = yohimbine. The inhibitory effect by propranolol could not be reversed by high concentrations of adrenaline or isoproterenol. In chromaffin cell monolayer cultures, all alpha 2-adrenoceptor agents tested (clonidine, oxymetazoline and yohimbine), produced a dose-dependent, Na+-sensitive, non-competitive inhibition of nicotine-induced catecholamine release with little effect on the catecholamine release induced by K+ (56 mM), histamine (10 microM) or Ba2+ (2.2 mM). (+/-)Propranolol caused a similar pattern of inhibition, however, this inhibition was also observed by (+)propranolol, an isomer with little beta-adrenoceptor antagonist activity. The effects of clonidine and propranolol on desensitization of nicotine-induced CA secretion were also investigated. The degree of desensitization of the nicotinic response was dependent on the concentration of nicotine to which the cells were pre-exposed. Desensitization was detected as the decrease in response to a near EC50 concentration of nicotine (5 microM) following pre-incubation of cells to nicotine in the range of 0.3-300 microM. The desensitization had a threshold of 1 microM nicotine and was maximal at 3 microM nicotine in the pre-incubation. Both clonidine (50 microM) and (+/-)propranolol (5 microM) inhibited CA secretion induced by nicotine (0.3 microM-300 microM) during the pre-incubation period. However, regardless of this inhibition of secretion, neither clonidine nor propranolol had an effect on either the onset, or the rate of nicotine-evoked desensitization subsequently observed. These data suggest that inhibition of the nicotinic response and desensitization of the nicotinic response are regulated independently.(ABSTRACT TRUNCATED AT 400 WORDS)
研究了多种α和β肾上腺素能受体激动剂及拮抗剂对牛肾上腺嗜铬细胞分泌调节的影响。通过尼古丁、56 mM K⁺、组胺或Ba²⁺诱导分泌,并采用ATP荧光素 - 荧光素酶生物发光技术或通过高效液相色谱结合电化学检测法测量内源性儿茶酚胺(CA)来进行检测。5 μM尼古丁诱导新鲜分离细胞释放ATP,仅受到肾上腺素和去甲肾上腺素的微弱抑制,即便如此也需要高浓度(大于500 μM),而多巴胺(1 μM - 1 mM)和异丙肾上腺素(100 μM)则无作用。可乐定(100 μM)、羟甲唑啉(100 μM)、育亨宾(100 μM)和普萘洛尔(5 μM)均能抑制尼古丁诱导的ATP释放,其效力顺序为:普萘洛尔>羟甲唑啉>可乐定 = 育亨宾。高浓度的肾上腺素或异丙肾上腺素无法逆转普萘洛尔的抑制作用。在嗜铬细胞单层培养中,所有测试的α₂肾上腺素能受体激动剂(可乐定、羟甲唑啉和育亨宾)均对尼古丁诱导的儿茶酚胺释放产生剂量依赖性、Na⁺敏感的非竞争性抑制,而对由56 mM K⁺、10 μM组胺或2.2 mM Ba²⁺诱导的儿茶酚胺释放影响较小。(±)普萘洛尔产生类似的抑制模式,然而,几乎没有β肾上腺素能受体拮抗活性的异构体(+)普萘洛尔也观察到了这种抑制作用。还研究了可乐定和普萘洛尔对尼古丁诱导的CA分泌脱敏的影响。烟碱反应的脱敏程度取决于细胞预先暴露于其中的尼古丁浓度。脱敏表现为细胞在0.3 - 300 μM尼古丁范围内预孵育后,对接近EC50浓度(5 μM)尼古丁的反应降低。脱敏的阈值为1 μM尼古丁,预孵育时在3 μM尼古丁时达到最大。在预孵育期间,可乐定(50 μM)和(±)普萘洛尔(5 μM)均抑制由尼古丁(0.3 μM - 300 μM)诱导的CA分泌。然而无论这种对分泌的抑制作用如何,可乐定和普萘洛尔对随后观察到的尼古丁诱发脱敏的起始或速率均无影响。这些数据表明,烟碱反应的抑制和烟碱反应的脱敏是独立调节的。(摘要截短至400字)